AstraZeneca AZN0.64%increase; green up pointing triangle has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell ...

A Utah mother who says she was “permanently disabled” after taking part in the US clinical trial of AstraZeneca’s COVID-19 vaccine is suing the drug manufacturer because it failed to cough ...

AstraZeneca's Covid vaccine – once heralded as a 'triumph for science' – is being withdrawn worldwide. The jab, developed with Oxford University, can no longer be used in the European Union ...

AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect. The exceedingly rare reaction is at the heart of a multi million-pound class ...

AstraZeneca is shelling out hundreds of millions to position itself to benefit from AI. Its competitors are following suit as the drug industry climbs onto the AI bandwagon. It'll be difficult for ...

AstraZeneca is acquiring Fusion Pharmaceuticals for up to $2.4 billion to expand its presence in the radiopharmaceuticals market. The acquisition includes Fusion's late-stage radiopharmaceutical ...

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday. Investors were clearly impressed by the pharmaceutical company's numbers ...

AstraZeneca’s first-quarter results (PDF) put a twist on a fairy tale, telling the lesser-known story of GOLDILOX and the porcupine. The drugmaker axed a cardiovascular disease prospect after ...